bpc-157 oral administration empty stomach or with food BPC 157 form BPC-157 for GERD: Healing Esophagus
Description
Summarizing, while current biological therapy which presumably seeks to target specific immune and biochemical abnormalities at the molecular and cellular level, the stable gastric pentadecapeptide BPC 157 evidence is more general, and from this point of view, even more suited for additional applications
doi: 10.1097/wnr.0000000000000071 Pubmed Abstract CrossRef Google Scholar View reference in article 52 ZhangWXieYWangTBiJLiHZhangLiQet al
Overall, clinical evidence supports its potential as a controlled research peptide for metabolic health studies, not as a therapeutic agent
It is studied in research contexts for its selective interaction with signaling pathways associated with lipid metabolism and energy regulation
some daily or oral options exist depending on the drug
